A large French cohort study finds that pregnant women with systemic sclerosis face increased risks of preeclampsia, preterm ...
Community-based CAR T-cell therapy improves access, reducing travel burdens and hospital admissions for patients with blood ...
Target Loadings of 4% and 5% Rapamycin Achieved for Topical Lotion and Dermal Patch Delivery Technologies Respectively ...
Women with systemic sclerosis were associated with a 60% higher risk for premature ovarian insufficiency. Women living with systemic sclerosis (SSc) face a significantly higher risk for premature ...
Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million ...
Spherix is a leading independent market intelligence and advisory firm that delivers commercial value to the global life sciences industry, across the brand lifecycle.
Background Pain and fatigue are among the most debilitating symptoms of systemic sclerosis (SSc), severely impairing quality ...
Amgen’s (AMGN) treatment of systemic sclerosis, blinatumomab, was granted FDA orphan designation, according to a post to the agency’s site. Take advantage of TipRanks Premium at 50% off! Unlock ...
Medicare expenditures for patients with amyotrophic lateral sclerosis are more than 3 times those of the average Medicare beneficiary, and drug therapies are an important cost driver. Objectives: To ...
Target Loadings of 4% and 5% Rapamycin Achieved for Topical Lotion and Dermal Patch Delivery Technologies Respectively Clinical Trial and Stability Batch Manufacture to Commence in Q4 2025 Clinical Te ...
Systemic light chain (AL) amyloidosis is a rare and life-threatening disorder characterized by the deposition of misfolded immunoglobulin light chains as insoluble amyloid fibrils in various tissues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback